期刊文献+

左西孟旦治疗心力衰竭患者的护理 被引量:2

Nursing of heart failure patients treated with levosimendan
下载PDF
导出
摘要 目的探讨左西孟旦治疗心力衰竭患者的护理要点。方法对6例使用左西孟旦治疗的心力衰竭患者的用药护理、不良反应的观察进行分析和总结。结果 5例患者使用左西孟旦后心力衰竭症状有所改善,6例患者1周后复查B型脑钠肽,均有不同程度的下降。不良反应主要有1例患者出现嗜睡症状。结论左西孟旦可降低心力衰竭患者的B型脑钠肽。临床护士对药物的作用机制、用药方法和不良反应的了解有利于指导护理人员进行正确有效的护理。 Objective To explore the nursing of heart failure patients treated with levosimendan.Methods Six heart failure patients received levosimenda.The nursing and adverse events were observed and analyzed.Results Heart failure symptoms were relieved in 5 patients after levosimendan was administered.B-type natriuretic peptide(BNP) was reexamined in a week and the level of it in all patients was decreased to varying degrees.The main adverse event was lethargy which was identified in only one patient. Conclusion Levosimendan can decrease BNP of heart failure patients.Nurses should understand the mechanism,methods of administration and adverse events of levosimendan to provided effective nursing.
出处 《实用临床医药杂志》 CAS 2012年第6期26-28,共3页 Journal of Clinical Medicine in Practice
关键词 左西孟旦 心力衰竭 护理 levosimendan heart failure nursing
  • 相关文献

参考文献9

  • 1Gheorghiade M, Teerlink J R, Mebazaa A. Pharmacology of New Agents for Acute Heart Failure Syndromes [ J ]. Am J Cardiol, 2005, 96: 68.
  • 2Michaels A D, McKeown B, Kostal M, et al. Effects of intravenous levosimendan on human coronary vasomotor regulation, leftventricular wall stress, and myocardial oxygen uptake[J]. Circulation, 2005, 111: 1504.
  • 3Maytin M, Colucci W S. Cardioprotection:A new paradigm in the management of acute heart failure syndromes [ J ]. Am J Cardiol, 2005, 96(Supp1): 26G.
  • 4程小敏,马淑梅.左西孟旦治疗心力衰竭的临床应用及安全性评价[J].实用药物与临床,2009,12(2):125-126. 被引量:19
  • 5Kivikko M, Antila S, Eha J, et al. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure[J]. J Clin Pharmacol, 2002, 42(1) : 43.
  • 6Figgitt D P, Gillies P S, Goa K L. Levosimendan[J]. Drugs, 2001, 61(5): 613.
  • 7姚道阔,贾三庆.左西孟旦在心力衰竭中的应用[J].中国综合临床,2007,23(11):1054-1056. 被引量:6
  • 8Papp Z, Csapo K, Pollesello P, et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan[ J ]. Cardiovasc Drug Rev, 2005, 23(1): 71.
  • 9张明玺,段延鹏,程冲,韩宁,罗开选.左西孟旦在老年重症急性左心衰中的应用[J].郧阳医学院学报,2009,28(4):373-374. 被引量:10

二级参考文献41

  • 1Kivikko M, Antila S, Eha J, ctal. Pharmacokinctics of Ievosimcndan and its mctabolites during and after a 24-hour continuous infusion in patients with severe heart failure[ J]. Int J Clin Pharmacoi Ther,2002,40(10) :465-471.
  • 2Ghcorghiade M, Tecdink JR, Mebazaa A. Pharmacology of New Agents for Acute Heart Failure Syndromes [ J ]. Am J Cardiol,2005 ,96 :68-73.
  • 3Sonntag S, Sundburg S, Lehtonen LA, et al. The Calcium Sensitizer Levosimendan Improves the Function of Stunned Myocardium After Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Ischemia [ J ]. J Am Coll Cardiol, 2004,43(12) :2177-2182.
  • 4Michaels AD, McKeown B, Kostal M,ct al. Effects of intravenous levosimendan on human coronary vasomotor regulation, leftventricular wall stress, and myocardial oxygen uptake[ J]. Circulation ,2005,111 : 1504-1509.
  • 5Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes [J ]. Am J Cardiol,2005,96(Suppl) :26G-31G.
  • 6Adamopoulos, Parissis JT, Iliodromitis EK,et al. Effects of Levosimendan Versus Dobutamine on Inflammatory and Apoptotic Pathways in Acutely Decompensated Chronic Heart Failure [ J]. Am J Cardiol,2006,98( 1 ) :102-106.
  • 7Cleland JG, Nikitin N, McGowan J. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure[ J]. Expert Rev Cardiovasc Ther,2004,2( 1 ) :9-19.
  • 8McMurray J ,Pfeffer MA. New therapeutic options in congestive heart failure: Part H[J ]. Circulation, 2002, 105 ( 18 ) : 2223 -2228.
  • 9Nieminen MS, Akkila J,Hasenfuss G,et al. Hemodynamic and ncurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure[ J]. J Am Coll Cardiol,2000,36(6) :1903-1912.
  • 10Moiseyev VS,Poder P,Andrejevs N,et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infaretion:a randomized, place bocontrolled, double-blind study ( RUSS- LAN) [J]. Eur Heart J,2002,23(18) :1422-1432.

共引文献28

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部